Biomedicine Inistitute of Anhui Medical University
Hefei, Anhui, 230032, China
NCT Number: NCT00693199
The aim of this study was to investigate the efficacy and safety of low dose amlodipine alone, or combined with low dose terazosin in male patients with both lower urinary tract symptoms and hypertension.
Looking for future studies?
Notify Me50 year and older
Male
Interventional
Not applicable
Hefei, Anhui, 230032, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
amlodipine 5mg once daily for 28 days
terazosin 2 mg once daily for 28 days
amlodipine 5 mg plus terazosin 2 mg once daily for 28days
Time frame: 28th day after treatment
Anhui Medical University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04557748
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Chicago, Illinois, United States
View Trial DetailsNCT07715448
Benign Prostatic Hyperplasia, Ejaculatory Dysfunction
Banī Suwayf, Beni Suef Governorate, Egypt
View Trial DetailsNCT04114266
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Ghent, Belgium
View Trial DetailsNCT06251557
Lower Urinary Tract Symptoms, Pathological Conditions, Signs and Symptoms
Ankara, Turkey (Türkiye)
View Trial Details